Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Plus Therapeutics, Inc., a clinical-stage healthcare company focused on central nervous system cancers, announced inducement awards totaling options and restricted stock units for two new employees. The awards are aimed at recruiting and retaining talent to advance the company's pipeline in targeted radiotherapeutics for difficult CNS cancers.